Rasio rega marang prakiraan pendapatan LakeShore Biopharma (LSB)

YS Biopharma Co., Ltd. - logo grafis emiten LSB

How does the PRC's state procurement system impact the position of LakeShore Biopharma Co. (LSB)? LakeShore Biopharma Co. (LSB) maintains its leadership through unique cell-free synthesis, which ensures high vaccine purity and pricing power. Revenues are based on government orders and immunization schedules, creating moderate stability in cash flows. The forward P/S ratio smooths out the noise during the post-crisis recovery, while the 1.30 mark reflects the current state of fundamental expectations.

LSB LakeShore Biopharma: Kapitalisasi marang prakiraan pendapatan ing interval 06.10.2024 - 07.10.2024

YS Biopharma Co., Ltd. (LSB) - rincian metrik lan laporan keuangan

- rega saiki lan proyeksi nilai saham:
Rega saham LakeShore Biopharma|LSB - Target median analis
- rincian kapitalisasi pasar:
Nilai pasar LSB|LSB - Total Nilai Perusahaan
- indikator nilai buku ekuitas:
Aset Bersih saben Siji Saham LakeShore Biopharma|LSB - Kapitalisasi Akuntansi|Rasio Nilai Pasar marang Nilai Buku ysbiopharm.com|LSB - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas LakeShore Biopharma Co.|LSB - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal LakeShore Biopharma Co.|LSB - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku LSB|LSB - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan LakeShore Biopharma|Likuiditas cepet ysbiopharm.com
- data bathi bisnis lan rasio investasi:
LSB - Asil keuangan resik|Proyeksi bathi mangsa ngarep LakeShore Biopharma Co.|LSB - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep YS Biopharma|LSB - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan LSB|LSB - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) LakeShore Biopharma|LSB - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan ysbiopharm.com|LSB - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep LakeShore Biopharma Co.
- indikator dodolan lan pendapatan:
LSB - Pendapatan perusahaan|Prakiraan volume dodolan LakeShore Biopharma|LSB - Koefisien rega marang pendapatan|Rasio rega marang prakiraan pendapatan LSB
Analisis fundamental perusahaan:LSB (LakeShore Biopharma)
Produk asli YS Biopharma Co., Ltd.

Analyzing LakeShore Biopharma Co. (LSB) through the company's forward P/S ratio allows for an assessment of the business's market value relative to expected sales volume. This multiple compares current market capitalization with future revenue, reflecting investment expectations regarding vaccine demand in China and the success of new biopharmaceutical developments. Sharp fluctuations in this indicator signal a shift in the market's valuation of the company's potential in the production of anti-infective drugs.

Pesaing LakeShore Biopharma Co.

Multiplikator Forward P/S SMMT (Summit Therapeutics Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake Moderna Inc (MRNA)|PCVX - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Tarsus Corp|CorMedix Inc. (CRMD) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan MCRB|Rasio rega marang prakiraan pendapatan Spero Therapeutics, Inc.|Scynexis (SCYX) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan AN2 Therapeutics, Inc. (ANTX)|Rasio rega marang prakiraan pendapatan PYPD (polypid.com)|Multiplikator Forward P/S ITRM (Iterum Therapeutics)|Multiplikator Forward P/S BiomX Inc PHGE|SNGX - Rasio rega marang prakiraan pendapatan|SXTP - Multiplikator Forward P/S|OGEN: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep OpGen Corporation (OPGN)